Resmetrix | Wearable Respiratory Monitoring System

Clinical Need

Deterioration in respiratory condition of Corona-virus (COVID-19), Asthma, COPD and Pneumonia patients is detected too late, leading to complications and death.

CORONA

Hundreds of thousands of people are now infected with Corona virus and require tight monitoring of their clinical condition from a distance, especially their lung function, both at home or isolated area and at the hospital. Many mild patients are deteriorating fast, reaching severe pneumonia and require mechanical ventilation and are at high risk of death. Late detection of this deterioration can be lethal.

Moderate Corona patients - at risk of late detection of further respiratory deterioration within the hospital.

Recovered Corona patients - can be discharged early to quarantine environment.

COPD and ASTHMA

Late detection of life threatening attacks in home environment.

In COPD, 20% of hospitalized patients get readmitted within 30 days following their initial hospital discharge.

By the Numbers United States:

Asthma - 25 Million Patients; 439K Inpatient Annually; 1.8M ER Visits Annually Total Cost to System: $82B
COPD - 16+ Million Patients; 3rd Leading Cause of Death Readmission Rate: 19.2%; Total Cost to System: $32B

RESMETRIX SOLUTION: EARLY DETECTION OF RESPIRATORY DETERIORATION

Resmetrix has developed a novel wearable respiratory monitoring system, that accurately monitors the respiratory pattern of respiratory disease patients (COVID-19, COPD, Asthma) and alert to the patient smartphone, and the medical team, when early signs of respiratory deterioration occur.

Resmetrix unique wearable sensor (based on novel proprietary sensor built into a chest strap or a patch over the chest), wirelessly connected to a smartphone app, monitors at-risk patients in real-time, 24/7, anywhere, in any setting. Resmetrix system is the only system that detects small changes in a patient’s breathing pattern, tidal volume and other vital signs (Heart Rate, Temperature) and will provide immediate, early warning signs of deterioration in lung function (based on each patient respiratory pattern).

Our tele-monitoring system can monitor Corona patients at home, at quarantine environment or at the Hospital, send alarm to the medical teams when patients are starting to deteriorate, so they can provide treatment early, hence avoiding lung failure and death.

Resmetrix Technology

Monitoring respiratory situation from Hospital-to-Home – 24/7 - 365

The Resmetrix innovative wearable respiratory monitoring system is a comfortable chest strap that continuously and accurately monitors respiratory patterns of the patient, whether in the hospital, at home, exercising, traveling, or in a living facility. The device wirelessly connects to a smartphone app that displays the respiratory parameters and vital signs in real time and can communicate episodes (exacerbations) early to enable quick attention and rapid clinician response.

The device is seamless to the patient, requiring no interaction or management to enable its continuous monitoring of lung performance and other related health indicators.

The Resmeterix System features a chest-strap powered by a proprietary, patented sensor enabling continuous, and accurate monitoring of breathing-patterns and detection of deterioration and improvement in respiratory trends. The strap includes heart rate measurements, temperature, activity and position sensors. The system utilizes a unique AI-Powered algorithm that assesses disease progression, based on the breathing patterns and trends, predict and alert on exacerbations and response to treatment.

The system’s smartphone/tablet app provides continuous, interactive real-time access to respiratory and vital signs for the patient and clinicians. The UX not only delivers health performance, but also encourages patient compliance, and utilizes an array of alarms for early signs of exacerbations. All the data is managed securely through a cloud-based platform.

Resmetrix Technology

Monitoring respiratory situation from Hospital-to-Home – 24/7 - 365

The device is seamless to the patient, requiring no interaction or management to enable its continuous monitoring of lung performance and other related health indicators.

Clinical Validation

Clinical study at Rambam Medical Center:

Resmetrix clinical results show high correlation between respiratory signals from Resmetrix’ strap and a spirometer/flow meter tidal volume signals.
In asthmatic patients, the system detected successfully changes in respiratory patterns during mild attack and response to treatment.
Studies in exercise, the system demonstrate the ability to continuously and accurately monitor the respiratory signals in various levels of exercise.

Value Proposition

Home Monitoring: With early detection capabilities of patient deterioration and alerts for timely interventions, the Resmetrix system can provide clinicians the ability to manage and treat patient health at any time and in any setting – importantly preventing further deterioration, and unnecessary ER visits, hospitalizations, and re-admissions. The result is a financial savings to the system alongside more efficacious and safer care for patients.

Hospital: Continuous monitoring of breathing patterns throughout the in-facility care spectrum, will enable rapid intervention and response to patient’s deterioration giving providers greater capacity to dealing with a moment of crisis. Additionally, anywhere monitoring can alleviate ICU placement/admissions and allow facilities to potentially discharge of patients earlier with the security of real-time health data during transition to home or long-term care facility. The result is far more flexibility in time, cost, and patient management for the hospital.

Value Proposition

About Us

Resmetrix has developed unique portable respiratory monitoring system: A wearable wireless chest strap that monitors, records and analyses continuously and accurately breathing patterns and alerts for early signs of deterioration in a patient’s clinical condition. The system provides a platform of respiratory disease management.

Resmetrix is a portfolio company of MindUP incubator, a partnership of Medtronic, IBM, Pitango and Rambam Medical Center in Israel.

Publications:

Resmetrix won third place in RESI Innovation challenge (Boston, US, Sep. 2019):

resi-bostons-audience-selects-innovation-challenge-champions

israeli-startups-make-a-big-impact-at-resi

The Times of Israel:

Israeli Chest Strap Keeps Tabs On Pulmonary Patients Breathing

israel21c:

Wearable monitor could prevent rehospitalization for COPD

Resmetrix started crowdfunding with Together angels club platform:

www.tgt.co.il/resmetrix-medical/

Resmetrix publication December 2019:

www.web-mine.co.il/economics-and-business/resmetrix/

Team

Dr. Ari DeRowe, MD.

Co-founder & CMO

Head of Pediatric Otolaryngology, Sourasky Medical Center. Medical device inventor: InStent (tracheal stent), InFluENT (AIRvance™ System Medtronic), ByPass (endovascular device); 6 patents

Dr. Zvi Reznic, PhD

Co-Founder & CTO

PhD in electrical engineering. Co-founder, VP R&D and CTO of Amimon, acquired by Vitec group (LON: VTC). Inventor/co-inventor of 50 patents